October 26, 2015 | Chinese medical company Xizang Haisco Pharmaceutical Group (Haisco) has invested $10 million into Israeli medical device company, Endospan. As part of the deal, Haisco will have exclusive rights within China to distribute Endospan’s heart stents. Based in Herzliya, Endospan was founded by CEO Alon Shalev and CTO Rafi Benary, and has already raised $25 million, including financing from Sequoia Capital and the Accelmed Fund.
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments